Programs

  • Program 1 [2020]

    EDUCATION - TYPICALLY, IN AN EFFORT TO ENHANCE THE CARE OF PATIENTS WORLDWIDE, IPC DELIVERS A VARIETY OF EDUCATIONAL PROGRAMS FOR HEALTH CARE PROFESSIONALS AROUND THE WORLD. IN RESPONSE TO THE CANCELLATION OF MANY IN-PERSON CONGRESSES, IPC HELD FOUR REGIONALLY FOCUSED WEBINARS FOR DERMATOLOGISTS DURING 2020. VARIOUS TOPICS WERE COVERED, INCLUDING NEW TREATMENTS, TREATMENTS IN DEVELOPMENT, CO-MORBIDITIES, COVID-19, BIOMARKERS, PATHOGENESIS, DISEASE SEVERITY, AND INFECTIONS. IN ADDITION, IPC PARTICIPATED IN THE JAPANESE SOCIETY FOR PSORIASIS RESEARCH CONGRESS AND THE EADV ANNUAL CONGRESS. THESE SESSIONS FOCUSED ON PERSONALIZED MEDICINE, PATHOGENESIS, THE PATHOPHYSIOLOGY OF GPP, BIOLOGIC NAIVE PATIENTS, SELECTING A BIOLOGIC, AND MANAGING CHALLENGING CASES. (CONTINUED ON SCH O)IPC'S 2020 FELLOWSHIP PROGRAM WAS LAUNCHED EARLY IN THE YEAR, WITH FIVE FELLOWS SELECTED. HOWEVER, WITH THE ONSET OF THE PANDEMIC, ONLY ONE FELLOW WAS ABLE TO COMPLETE THE ONSITE PORTION OF THE PROGRAM. THE OTHER FOUR FELLOWS HAVE ELECTED TO DEFER THEIR FELLOWSHIP TO 2021.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $299.5K

  • Program 2 [2020]

    RESEARCH - IN RESPONSE TO THE COVID-19 PANDEMIC, THE IPC BOARD OF DIRECTORS (THE IPC BOARD) ISSUED A STATEMENT REGARDING ITS IMPACT ON PATIENTS WITH PSORIASIS AND ESTABLISHED A WEB-BASED RESOURCE CENTER. THE RESOURCE CENTER INCLUDES VIDEOS ON REAL-WORLD EXPERIENCES FROM PHYSICIANS AT THE FOREFRONT OF THE PANDEMIC, EXPERT OPINIONS ON PUBLISHED MANUSCRIPTS, LINKS TO TREATMENT GUIDELINES, AND INFORMATION ON THE PSOPROTECT AND THE PSOPROTECTME COVID-19 REGISTRIES WHICH IPC IS A GLOBAL PARTNER. DISEASE SEVERITY PROJECT: THE WORKING GROUP BEGAN WORKING ON THE FOLLOWING ACTION ITEMS: VALIDATE THE NEW CLASSIFICATION IN THREE DATA SETS OF PATIENT POPULATIONS; EDUCATE...(CONTINUED ON SCH O)DERMATOLOGISTS ON THE VALUE OF USING THE NEW CATEGORIZATION IN THEIR DAILY PRACTICE TO INCREASE THE NUMBER OF PATIENTS RECEIVING THE APPROPRIATE TREATMENT, AND ENGAGE WITH STAKEHOLDERS TO EMBRACE THE NEW DEFINITION, INCLUDING PATIENT ASSOCIATIONS, REGULATORY BODIES, AND INDUSTRY PARTNERS.GLOBAL PSORIASIS ATLAS PROJECT: PHASE TWO HAS BEEN INITIATED IN PARTNERSHIP WITH THE ILDS AND IFPA. THE UNIVERSITY OF MANCHESTER WILL CONTINUE TO SERVE AS THE LEAD ACADEMIC INSTITUTION FOR THE PROJECT. WORKSTREAMS FOR THE PROJECT INCLUDE EPIDEMIOLOGY OF PSORIASIS, EARLY DIAGNOSIS OF PSORIASIS, COMORBID DISEASE BURDEN OF PSORIASIS, AND THE ECONOMIC IMPACT OF PSORIASIS.BEST EVIDENCE REVIEW PAPER: THE IPC BOARD WILL SELECT A SPECIFIC SUBJECT OF IMPORTANCE AND COMMISSION A GROUP OF EXPERTS TO CONDUCT A BEST-EVIDENCE REVIEW ON THE SUBJECT. IN 2020, IPC CHOSE THE BIOMAP COLLABORATION TO SUPPORT THE COMPLETION OF A SYSTEMATIC REVIEW OF BIOMARKERS. THE MANUSCRIPT IS EXPECTED TO BE SUBMITTED TO A JOURNAL IN JANUARY/FEBRUARY 2021.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $144.8K

  • Program 3 [2020]

    OUTREACH AND OTHER PROGRAMS - IPC PARTICIPATES IN THE AMERICAN ACADEMY OF DERMATOLOGY (AAD), CONGRESO IBERO LATINOAMERICANO DE DERMATOLOGIA (CILAD), EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV), AND REUNION ANUAL DE DERMATOLOGOS LATINOAMERICANOS (RADLA) MEETINGS. EACH ORGANIZATION IS CHARGED WITH EDUCATING DERMATOLOGISTS AND SHARING BEST PRACTICES.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $141.2K